| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5537117 | Vaccine | 2017 | 7 Pages |
Abstract
The US military is a major consumer of S. Typhi vaccines. The parenterally administered vaccine appears to be more amenable, though we were limited in our ability to assess the reasons for its higher usage. While we observed a higher rate of several adverse events in subjects receiving the intramuscular vaccination, the overall rate of these events was low. Future studies assessing more long-term health outcomes are warranted.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Chad K. Porter, Tia Sorrell, Indrani Mitra, Mark S. Riddle,